WR Hambrecht Said Pfizer (PFE) May Buy Nektar (NKTR) Following Torcetrapib Blow-Up
Tweet Send to a Friend
Commenting on Nektar Therapeutics (Nasdaq: NKTR), WR Hambrecht said with Pfizer's (NYSE: PFE) loss on torcetrapib NKTR's stargegic value rises.
This article: 283 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 283 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
